骨髓纤维化

  • 网络myelofibrosis;PMF;Myelofibrosis,MF
骨髓纤维化骨髓纤维化
  1. ET患者发生血栓、出血、骨髓纤维化以及转变为急性髓系白血病的风险性较高。

    Patients with ET are at increased risk for developing thrombosis , hemorrhage , myelofibrosis and transformation to acute myeloid leukemia .

  2. 目的探讨bcr/abl融合基因的表达水平在慢性粒细胞白血病(CML)和原发性骨髓纤维化(MF)患者的诊断、疗效及预后观察中的意义。

    Objective : To study the level of bcr / abl fusion gene expression in the diagnosis , treatment and prognosis in chronic myelogenous leukemia ( CML ) and primary myelofibrosis ( MF ) .

  3. 原发性骨髓纤维化腰椎和骨盆的MRI和X线诊断探讨

    MRI findings and X-ray appearance of primary myelofibrosis in marrow of lumbar vertebra and pelvis

  4. G显带及常规染色体检查在白血病研究中的意义(附白血病28例及骨髓纤维化症2例的染色体核型分析)

    The Significance of Chromosomal Study with G-banding Technique and Giemsa Stain in Leukemia ( Karyotype Analysis of 28 Cases of Leukemia and 2 Cases of Myelofibrosis )

  5. 慢性粒细胞白血病(CML)、真性红细胞增多症(PV)、原发性血小板增多症(ET)、慢性特发性骨髓纤维化(CIMF)均归于典型MPD;

    Classic MPDs comprise four subtypes : chronic myeloid leukemia ( CML ), polycythemia vera ( PV ), essential thrombocythemia ( ET ) and chronic idiopathic myelofibrosis ( CIMF ) .

  6. 目的研究45岁以下原发性骨髓纤维化(PMF)患者的临床特点和影响生存期的预后因素。

    Objective To investigate the clinical and hematological features and identify the prognostic factors associated with short-term survival in primary myelofibrosis ( PMF ) patients under 45 years old .

  7. 干扰素用于治疗MPN无致白血病及骨髓纤维化作用,但其治疗后常会出现发热、肌肉关节痛等不良反应,部分患者不能耐受而停药。

    Interferon for the treatment of MPN non-induced leukemia and bone marrow fibrosis , but its treatment often lead to fever , muscle and joint pain and other adverse reactions , some patients can not tolerate the withdrawal .

  8. Nplate的安全性问题包括骨髓纤维化和存在下面状况的可能性,即一旦停用Nplate,血小板计数水平可能跌到最初开始治疗的水平之下。

    Safety concerns with Nplate include fibrous deposits in the bone marrow and the possibility that once Nplate is stopped , platelet counts could drop below what they were before beginning treatment .

  9. 结果原发性血小板减少性紫癜PAIgG阳性率为82.7%,系统性红斑狼疮为70%,甲亢为39.5%,肝硬化为71.8%,再障为37.5,骨髓纤维化为77%。

    Result The positive rates of PAIgG were 82.7 % in idiopathic thrombocytopenic purpura , 70 % in systemic lupus erythematosus , 39.5 % in hyperthyroidism , 71.8 % in cirrhosis of liver , 37.5 % in aplastic anemia and 77 % in marrow fibrosis .

  10. 急性白血病继发骨髓纤维化34例骨髓的活检

    A report of acute leukemia with reticulin myelofibrosis in 34 cases

  11. 地中海贫血与继发性骨髓纤维化的关系

    A Research On the Relation of Thalassemia to the Secondary Marrow Fibrosis

  12. 161例慢性特发性骨髓纤维化临床病理分期的探讨

    Study of 161 chronic idiopathic myelofibrosis patients for clinicopathological staging

  13. 骨髓纤维化临床与病理分析&关于分型问题的讨论

    Clinical and Pathologic Analysis of Bone Marrow Fibrosis & Discussion on classification

  14. 西双版纳热带人工雨林生物量及净第一性生产力的研究原发性骨髓纤维化(附5例报告)

    Biomass and net primary productivity of artificial tropical rainforest in Xishuangbanna .

  15. 维生素D3治疗急性骨髓纤维化取得缓解&附一例报告

    Remission of Acute Myelofibrosis after Vitamin D _3 Therapy : A Case Report

  16. 原发性骨髓纤维化(附5例报告)急性白血病继发骨髓纤维化34例骨髓的活检

    Primary Myelofibrosis A report of acute leukemia with reticulin myelofibrosis in 34 cases

  17. 80例继发性骨髓纤维化患者临床特点和骨髓活检分析

    The clinical features and bone marrow biopsy of 80 cases of secondary myelofibrosis

  18. 105例小儿血液病骨髓纤维化观察

    Observation of myelofibrosis in 105 cases of children hematopathy

  19. 方法:以二乙基亚硝胺为诱癌剂制造大鼠肝癌模型。原发性骨髓纤维化(附5例报告)

    METHODS : The primary liver carcinoma modle of rats was induced by diethylnitrosamine .

  20. 席汉综合征并发原发性骨髓纤维化1例

    Sheehan syndrome with primary myelofibrosis : one case

  21. 继发于恶性肿瘤骨髓纤维化症47例临床资料分析

    Clinical Analysis of 47 Cases of Myelofibrosis Secondary to Malignant Tumors and Literature Review

  22. 骨髓纤维化(14例报告分析)

    Myelofibrosis ( Report of 14 Cases )

  23. 沙利度胺治疗特发性骨髓纤维化的研究进展

    Advances in Thalidomide Therapy for Idiopathic Myelofibrosis

  24. 脾切除治疗原发性骨髓纤维化适应证的探讨

    Splenectomy in the treatment of primary myelofibrosis

  25. 原发性骨髓纤维化50例分析

    Primary myelofibrosis : analysis of 50 cases

  26. 结论:反应停是一种安全、经济、有效的治疗原发性骨髓纤维化的新方法。

    Conclusion : Thalidomide is a safety , economical , effective new method to treat IMF .

  27. 沙利度胺联合干扰素α-2b治疗原发性骨髓纤维化疗效观察

    Therapeutic Effect of Thalidomide Combined With Interferon - α - 2b for Treatment of Idiopathic Myelofibrosis

  28. 8例骨髓纤维化中4例临床血液学完全缓解,4例贫血症状得到改善。

    In 8 patients with myelofibrosis , 4 achieved CR clinically while the other 4 became better in anemia .

  29. 目的探讨原发性骨髓纤维化病人行脾切除术的手术指征、并发症和治疗效果。

    Objective To explore the surgical indications , complications and curative effectiveness of splenectomy in treating the patients with primary myelofibrosis .

  30. 初期骨髓纤维化的患者容易感觉疲劳,他们有时会服用贫血药来袭击携氧红细胞的生长。

    Patients with primary myelofibrosis feel fatigued , and they sometimes take an anemia drug to stimulate growth of oxygen-carrying red blood cells .